| scholarly article | Q13442814 |
| P2093 | author name string | T O'Sullivan | |
| D E Strandness | |||
| J R Horn | |||
| R L Carithers | |||
| L A Bauer | |||
| W G Reiss | |||
| K Opheim | |||
| P2860 | cites work | Single and multiple doses of oral cimetidine do not change liver blood flow in humans | Q68873028 |
| Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time | Q70336540 | ||
| Influence of sex and oral contraceptive steroids on antipyrine metabolite formation | Q70397454 | ||
| Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine | Q71186281 | ||
| Simplified high performance liquid chromatographic quantitation of antipyrine | Q71431536 | ||
| Hepatic circulation in cirrhosis of the liver | Q75985998 | ||
| The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function | Q78802805 | ||
| Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data | Q30558717 | ||
| Estimation of hepatic blood flow with indocyanine green | Q34021069 | ||
| Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
| Clearance concepts in pharmacokinetics | Q34218381 | ||
| Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach | Q34418061 | ||
| Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications | Q38023213 | ||
| Antipyrine as a model drug to study hepatic drug-metabolizing capacity | Q39652034 | ||
| Alterations in the disposition of differently cleared drugs in patients with cirrhosis | Q41677067 | ||
| Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man | Q41705893 | ||
| Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis | Q42040905 | ||
| The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease | Q42100414 | ||
| Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers | Q42285318 | ||
| Commentary: a physiological approach to hepatic drug clearance | Q43996648 | ||
| Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach | Q45278849 | ||
| Clearance of antipyrine-dependence of quantitative liver function | Q47864473 | ||
| Mechanism for reduced drug clearance in patients with cirrhosis | Q67292007 | ||
| The effects of oral nifedipine on hepatic blood flow in humans | Q68004988 | ||
| Disposition of drugs in cystic fibrosis. II. Hepatic blood flow | Q68004999 | ||
| Estimation of hepatic blood flow in branches of hepatic vessels utilizing a noninvasive, duplex Doppler method | Q68586198 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 375-381 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis | |
| P478 | volume | 37 |
| Q40959038 | Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update |
| Q43502957 | Effect of metoprolol and verapamil administered separately and concurrently after single doses on liver blood flow and drug disposition |
| Q73846452 | Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes |
Search more.